TR200101507T2 - Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri - Google Patents

Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri

Info

Publication number
TR200101507T2
TR200101507T2 TR2001/01507T TR200101507T TR200101507T2 TR 200101507 T2 TR200101507 T2 TR 200101507T2 TR 2001/01507 T TR2001/01507 T TR 2001/01507T TR 200101507 T TR200101507 T TR 200101507T TR 200101507 T2 TR200101507 T2 TR 200101507T2
Authority
TR
Turkey
Prior art keywords
hydrogen
pyridiniummethyl
cefem
imidazo
compositions
Prior art date
Application number
TR2001/01507T
Other languages
English (en)
Inventor
Nishitani Yasuhiro
Itani Hikaru
Irie Tadashi
Original Assignee
Shionogi & Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co., Ltd. filed Critical Shionogi & Co., Ltd.
Publication of TR200101507T2 publication Critical patent/TR200101507T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

X'in N veya CY ve Y'nin H veya halojen; R1'in amino veya korumali amino; R'nin hidrojen, tercihe göre ikameli alt alkil, vs; R3'ün hidrojen vs; R4'ün hidrojen, tercihe göre ikameli alt alkil veya tercihe göre ikameli N-içeren heterosiklik grup vs; R5'in hidrojen vs; ve kivrimli çizginin bir sin-veya antiizomerizmi, veya bir karisimi oldugu bir formül (1); sefem bilesimi, MRSA dahil, çesitli patojenik bakterilere karsi genis antibakteriyel spektrum göstermektedir.
TR2001/01507T 1998-11-27 1999-11-25 Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri TR200101507T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33670798 1998-11-27

Publications (1)

Publication Number Publication Date
TR200101507T2 true TR200101507T2 (tr) 2001-09-21

Family

ID=18301969

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01507T TR200101507T2 (tr) 1998-11-27 1999-11-25 Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri

Country Status (23)

Country Link
US (2) US6518263B1 (tr)
EP (1) EP1134222B1 (tr)
JP (1) JP3636663B2 (tr)
KR (1) KR100692169B1 (tr)
CN (1) CN100436456C (tr)
AT (1) ATE293114T1 (tr)
AU (1) AU758662B2 (tr)
BR (1) BR9915743A (tr)
CA (1) CA2350905C (tr)
CZ (1) CZ20011719A3 (tr)
DE (1) DE69924751T2 (tr)
ES (1) ES2241374T3 (tr)
HU (1) HUP0200450A3 (tr)
ID (1) ID28740A (tr)
IL (1) IL143314A0 (tr)
NO (1) NO20012554L (tr)
NZ (1) NZ511619A (tr)
PL (1) PL347897A1 (tr)
RU (1) RU2223964C2 (tr)
TR (1) TR200101507T2 (tr)
TW (1) TW526202B (tr)
WO (1) WO2000032606A1 (tr)
ZA (1) ZA200103850B (tr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6846819B1 (en) 1999-10-08 2005-01-25 Affinium Pharmaceuticals, Inc. Fab I inhibitors
JP2003012647A (ja) * 2000-10-04 2003-01-15 Shionogi & Co Ltd ２，３−ジアミノピリジンの製造方法
US7049310B2 (en) * 2001-04-06 2006-05-23 Affinium Pharmaceuticals, Inc. Fab I inhibitors
EP1382608B1 (en) * 2001-04-23 2005-08-31 Shionogi & Co., Ltd. Sulfate of cephem compound
JP4416111B2 (ja) * 2002-02-14 2010-02-17 塩野義製薬株式会社 ２，３−ジアミノピリジン誘導体の製造方法
DE60321548D1 (de) * 2002-03-13 2008-07-24 Janssen Pharmaceutica Nv Carbonylamino- derivativate als neue inhibitoren von histone deacetylase
WO2004000323A1 (ja) * 2002-06-21 2003-12-31 Shionogi & Co., Ltd. セフェム化合物の注射用医薬組成物
AU2003264462A1 (en) * 2002-09-20 2004-04-08 Shionogi And Co., Ltd. Process for the preparation of cephems
JPWO2004039816A1 (ja) * 2002-10-29 2006-03-02 塩野義製薬株式会社 セフェム化合物の無機酸塩の結晶
AU2002952355A0 (en) * 2002-10-30 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
ATE368042T1 (de) * 2002-10-30 2007-08-15 Astellas Pharma Inc Cephemverbindungen
ES2518316T3 (es) * 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
DE602004016831D1 (de) * 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JP4643577B2 (ja) * 2003-09-18 2011-03-02 アステラス製薬株式会社 セフェム化合物
JP4535366B2 (ja) * 2003-12-03 2010-09-01 塩野義製薬株式会社 セフェム剤の製造方法
TW200530255A (en) * 2004-03-05 2005-09-16 Shionogi & Co 3-pyridiniummethylcefem compound
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
JP2006206529A (ja) * 2005-01-31 2006-08-10 Shionogi & Co Ltd Ｎ−（４−ピリジル）エチレンジアミン誘導体
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
US8198434B2 (en) * 2008-05-07 2012-06-12 Idexx Laboratories, Inc. Process for preparing cefsulodin sodium
CN102443017B (zh) * 2010-10-13 2014-10-29 石药集团中奇制药技术（石家庄）有限公司 一种盐酸头孢唑兰的制备方法
CA2848012A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
RS58898B1 (sr) 2012-06-19 2019-08-30 Debiopharm Int Sa Prolek derivati (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamida
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
HUE043853T2 (hu) 2012-10-12 2019-09-30 Broad Inst Inc GSK3 inhibitorok és eljárások azok alkalmazására
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN107787324B (zh) * 2015-06-29 2020-05-19 桑多斯股份公司 氨甲酰基氨基吡唑衍生物的制备方法
WO2017096472A1 (en) * 2015-12-10 2017-06-15 Naeja-Rgm Pharmaceuticals Inc. Cephem compounds, their production and use
TN2018000293A1 (en) 2016-02-26 2020-01-16 Debiopharm Int Sa Medicament for treatment of diabetic foot infections
EP3606528B1 (en) 2017-04-05 2023-10-18 The Broad Institute, Inc. Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585199A (en) * 1967-05-25 1971-06-15 Merck & Co Inc (4-(3-(polyazaheterocyclic)alkanoyl)phenoxy)alkanoic acids
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
GR75644B (tr) 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
ES511101A0 (es) 1981-04-03 1983-05-01 Fujisawa Pharmaceutical Co "procedimiento para preparar un nuevo compuesto de cefem".
PL238158A1 (en) 1981-09-08 1984-11-19 Lilly Co Eli Method of obtaining new cephalosporin derivatives
US4406899A (en) 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
ZA838864B (en) * 1982-12-17 1984-11-28 Ici Pharma Process for the manufacture of cephalosporin derivatives
DE3248281A1 (de) 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
US4525473A (en) 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3336757A1 (de) 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3409431A1 (de) 1983-10-08 1985-04-18 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4692443A (en) * 1983-10-17 1987-09-08 Eli Lilly And Company 3-bicyclicpyridinium-methyl cephalosporins
EP0138552A3 (en) * 1983-10-17 1986-03-19 Eli Lilly And Company Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins
JPS60120889A (ja) 1983-11-30 1985-06-28 Meiji Seika Kaisha Ltd 新規セファロスポリン化合物及びその製造法
US4547573A (en) 1983-12-02 1985-10-15 Ici Pharma Process for preparing cephalosporin derivatives
GB8401093D0 (en) 1984-01-16 1984-02-15 Fujisawa Pharmaceutical Co Cephem compounds
NO165842C (no) 1984-04-23 1991-04-17 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
IL77458A (en) 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
EP0203271B1 (en) 1985-03-01 1993-05-26 Takeda Chemical Industries, Ltd. Antibacterial compounds, their production and use
ATE89826T1 (de) 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4804658A (en) * 1986-09-15 1989-02-14 G. D. Searle & Co. Imidazopyridine derivatives and pharmaceutical compositions
GB8712747D0 (en) * 1987-05-30 1987-07-01 Pfizer Ltd Therapeutic agents
JPH0248587A (ja) * 1988-08-10 1990-02-19 Yamanouchi Pharmaceut Co Ltd 複素環置換ビスフォスフォン酸誘導体及びその医薬
JPH02286679A (ja) * 1989-04-28 1990-11-26 Grelan Pharmaceut Co Ltd イミダゾピリジン誘導体
US5332744A (en) 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5298518A (en) 1989-09-29 1994-03-29 Eisai Co., Ltd. Biphenylmethane derivative and pharmacological use
EP0434038A1 (en) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
DE4005970A1 (de) 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH04235974A (ja) * 1990-06-08 1992-08-25 Roussel Uclaf 新規なイミダゾール誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
WO1992006086A1 (en) * 1990-10-01 1992-04-16 Janssen Pharmaceutica N.V. Novel 4-piperidinylcarbonyl derivatives
US5281589A (en) * 1991-06-15 1994-01-25 Cheil Foods & Chemicals, Inc. 3-fused pyridiniummethyl cephalosporins
JPH05201991A (ja) * 1991-07-10 1993-08-10 Dainippon Pharmaceut Co Ltd アミノ酸誘導体
JPH05222058A (ja) 1992-02-17 1993-08-31 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
JPH0641149A (ja) * 1992-05-28 1994-02-15 Toyama Chem Co Ltd 新規なセファロスポリン誘導体およびその塩
JP3269658B2 (ja) * 1992-06-02 2002-03-25 エーザイ株式会社 フェノール誘導体
GB9216287D0 (en) 1992-07-31 1992-09-16 Fujisawa Pharmaceutical Co New cephem compounds
JPH07101958A (ja) 1992-10-16 1995-04-18 Takeda Chem Ind Ltd セフェム化合物、その製造法および抗菌組成物
US5334598A (en) * 1993-03-19 1994-08-02 Merck & Co., Inc. Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
DE4309969A1 (de) 1993-03-26 1994-09-29 Bayer Ag Substituierte heteroanellierte Imidazole
JPH07101960A (ja) 1993-10-05 1995-04-18 Takeda Chem Ind Ltd セフェム化合物、その製造法および抗菌組成物
US5486525A (en) 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
DE4416433A1 (de) * 1994-05-10 1995-11-16 Hoechst Ag Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten
US5585492A (en) 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US5635514A (en) * 1994-10-25 1997-06-03 G. D. Searle & Company Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors
US5846990A (en) 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09165371A (ja) * 1995-10-09 1997-06-24 Sankyo Co Ltd 複素環化合物を含有する医薬
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
AUPN955596A0 (en) 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0934941A1 (en) 1996-08-09 1999-08-11 Eisai Co., Ltd. Benzopiperidine derivatives
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity

Also Published As

Publication number Publication date
ES2241374T3 (es) 2005-10-16
BR9915743A (pt) 2001-08-21
NO20012554D0 (no) 2001-05-23
EP1134222A1 (en) 2001-09-19
RU2223964C2 (ru) 2004-02-20
IL143314A0 (en) 2002-04-21
NZ511619A (en) 2002-11-26
US6800621B2 (en) 2004-10-05
EP1134222A4 (en) 2003-01-29
KR20010086058A (ko) 2001-09-07
US20030149014A1 (en) 2003-08-07
AU1409000A (en) 2000-06-19
ATE293114T1 (de) 2005-04-15
KR100692169B1 (ko) 2007-03-12
HUP0200450A2 (hu) 2002-07-29
WO2000032606A1 (fr) 2000-06-08
CA2350905C (en) 2007-10-23
CN100436456C (zh) 2008-11-26
HUP0200450A3 (en) 2004-04-28
ZA200103850B (en) 2002-05-13
DE69924751D1 (de) 2005-05-19
NO20012554L (no) 2001-07-27
TW526202B (en) 2003-04-01
EP1134222B1 (en) 2005-04-13
JP3636663B2 (ja) 2005-04-06
US6518263B1 (en) 2003-02-11
CZ20011719A3 (cs) 2001-12-12
CN1333776A (zh) 2002-01-30
ID28740A (id) 2001-06-28
PL347897A1 (en) 2002-04-22
CA2350905A1 (en) 2000-06-08
AU758662B2 (en) 2003-03-27
DE69924751T2 (de) 2006-03-09

Similar Documents

Publication Publication Date Title
TR200101507T2 (tr) Geniş antibakteriyel spektrumu olan imidazo[4,5-b] piridinyummetil-içerikli sefem bileşimleri
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
GB2439881C (en) Pyrrolobenzodiazepines
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
PT1070056E (pt) Inibidores de pde iii/iv a base de ftalazinona
TR200000197T2 (tr) Yeni bileşimler
BR0213140A (pt) Fungicidas de pirazol-pirimidina
TR199900856T2 (tr) Bronsla ilgili terapi maddeleri olarak benzonaftiridinler
SE9702773D0 (sv) Novel compounds
PL341239A1 (en) Dihydrobenzofuranes
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
TR200001950T2 (tr) İkameli 2-benzilamino-2-fenil-asetamid bileşikler.
MXPA05010651A (es) Compuestos de pirazol.
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
SI1377574T1 (tr)
SE9802574D0 (sv) Novel compounds
DE60125053D1 (de) Cephem verbindungen und diese enthaltende esbl nachweisreagenzien
CA2355711A1 (en) Fungicide mixture
TR200103332T2 (tr) 1-Triflorometil-4-hidroksi-7-piperidinil-aminometilkroman türevleri.
RS20060205A (en) Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
ATE280792T1 (de) Aromatische aminhärter und ihre verwendung
WO1999059996A8 (en) Antitumour 1,5-diazaanthraquinones
BR0317151A (pt) Misturas de agentes de branqueamento fluorescentes
YU23498A (sh) Herbicidni 3,5-difluoropiridini
MXPA05008839A (es) Derivados de imidazo[4,5-b]quinolina y su uso como inhibidores de no-sintasa.